| 1 |
33309519 | Molecular pharmacology of P2Y receptor subtypes. | 2021 May |
1 |
| 2 |
31764002 | Purification and characterization of a thrombin-like enzyme isolated from Vipera lebetina venom: its interaction with platelet receptor. | 2020 Jan |
1 |
| 3 |
30922852 | Pharmacology of P2Y receptors. | 2019 Sep |
1 |
| 4 |
24433137 | Ticagrelor as an alternative in clopidogrel-associated neutropenia. | 2015 |
1 |
| 5 |
22963529 | P2Y12 inhibitors: pharmacologic mechanism and clinical relevance. | 2013 Jun |
1 |
| 6 |
23839753 | Medical management after coronary stent implantation: a review. | 2013 Jul 10 |
1 |
| 7 |
22360514 | A critical appraisal of the functional evolution of P2Y12 antagonists as antiplatelet drugs. | 2012 |
1 |
| 8 |
22906899 | Impact of antiplatelet therapy in heart disease. | 2012 |
1 |
| 9 |
22918731 | Thienopyridines and other ADP-receptor antagonists. | 2012 |
2 |
| 10 |
21554368 | P2Y12 receptor gene mutation associated with postoperative hemorrhage in a Greater Swiss Mountain dog. | 2011 Jun |
1 |
| 11 |
21946108 | Direct formation of thienopyridine-derived nitrosothiols--just add nitrite! | 2011 Nov 30 |
1 |
| 12 |
20831051 | [Thienopyridines in the treatment and prevention of cardiovascular diseases. Part V. Combination of clopidogrel and acetylsalicylic acid in the treatment of stable patients with atherothrombotic cardiovascular diseases]. | 2010 |
1 |
| 13 |
20977463 | Inhibition of vascular ectonucleotidase activities by the pro-drugs ticlopidine and clopidogrel favours platelet aggregation. | 2010 Nov |
1 |
| 14 |
19334620 | [Genetic variants of platelet ADP receptor P2Y12 associated with changed platelet functional activity and development of cardiovascular diseases]. | 2009 Feb |
1 |
| 15 |
19463124 | [Thienopyridines in the treatment and prevention of cardiovascular diseases. Part I. Ticlopidine]. | 2009 |
1 |
| 16 |
19845526 | [Thienopyridines in the treatment and prevention of cardiovascular diseases. Part II. Clinical pharmacology of clopidogrel]. | 2009 |
1 |
| 17 |
20038285 | [Thienopyridines in the treatment and prevention of cardiovascular diseases. III. therapeutic application of clopidogrel as monotherapy (without acetylsalicylic acid)]. | 2009 |
1 |
| 18 |
20038286 | [Thienopyridines in the treatment and prevention of cardiovascular diseases. Part IV. therapeutic application of clopidogrel in combination with acetylsalicylic acid in acute coronary syndromes and percutaneous coronary interventions]. | 2009 |
1 |
| 19 |
17187456 | Platelet P2 receptors: old and new targets for antithrombotic drugs. | 2007 Jan |
1 |
| 20 |
16245416 | [Place of ticlopidine in antiplatelet treatment]. | 2005 Aug |
1 |
| 21 |
14717977 | Gi-dependent and -independent mechanisms downstream of the P2Y12 ADP-receptor. | 2004 Jan |
1 |
| 22 |
12913786 | Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis. | 2003 Sep |
1 |
| 23 |
14610915 | ADP receptor antagonists as antiplatelet therapeutics. | 2003 May |
2 |
| 24 |
11245644 | Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial. | 2001 Mar 13 |
1 |
| 25 |
11454254 | The P2Y12 receptor as a therapeutic target in cardiovascular disease. | 2001 Jun |
2 |